
Published On: Mar 2021
Published On: Mar 2021
Media and Reagent Segment Held Largest Share of Product in Middle East and Africa Cell Line Development Market in 2019
According to a new market research study of ‘Middle East and Africa cell line development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by type, product, and application’ the Middle East and Africa cell line development market is expected to reach US$ 626.07 million in 2027 from US$ 247.84 million in 2019. The market is estimated to grow with a CAGR of 12.4% from 2020-2027. The report provides trends prevailing in the Middle East and Africa cell line development market and the factors driving market along with those that act as hindrances.
Based on product, the cell line development market is segmented into equipment, and media and reagent. The media and reagent segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. The media and reagent segment's growth is fuelled as media and reagents are important part of the cell line development process. For instance, trypan blue dye is used to differentiate between live and dead cells. Trypan blue is not absorbed by healthy viable cells. Thus, making it easy to differentiate.
The growth of this market is estimated to grow owing to key driving factors such as the increasing focus on the research and development activities regarding cell line development market and a higher prevalence of cancer cases. However, the market growth is likely to be hindered owing to the several issues related to the cell line development market.
WuXi AppTec, Merck KGaA , and Lonza are among the leading companies operating in the Middle East and Africa cell line development market.
The report segments Middle East and Africa Cell Line Development Market as Follows:
By Type
By Product
By Application
By Country